The Ultimate Resource for Pharmaceutical SOPs and Best Practices
SOP for Reconstitution Testing Standard Operating Procedure for Reconstitution Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting reconstitution testing of pharmaceutical products, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure that the product can be properly reconstituted prior to administration. 2) Scope This SOP…
SOP for Temperature Mapping in Storage Areas Standard Operating Procedure for Temperature Mapping in Storage Areas 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting temperature mapping in storage areas where pharmaceutical products, including Intramuscular (IM) and Subcutaneous (SC) injections, are stored to ensure that the environmental…
SOP for Packaging Integrity Testing Standard Operating Procedure for Packaging Integrity Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting packaging integrity testing of pharmaceutical products, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure that the packaging provides adequate protection to the product. 2) Scope…
SOP for Bioburden Testing Standard Operating Procedure for Bioburden Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting bioburden testing of pharmaceutical formulations, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure the microbial quality and safety of the product. 2) Scope This SOP applies to…
SOP for Emulsion Stability Testing Standard Operating Procedure for Emulsion Stability Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for conducting emulsion stability testing of pharmaceutical formulations, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure the stability and efficacy of the product. 2) Scope This SOP…
SOP for Viscosity Testing Standard Operating Procedure for Viscosity Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting viscosity testing of pharmaceutical formulations, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure consistency and appropriate flow characteristics of the product. 2) Scope This SOP applies to…
SOP for Homogeneity Testing Standard Operating Procedure for Homogeneity Testing 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for conducting homogeneity testing of pharmaceutical formulations, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure uniform distribution of the active pharmaceutical ingredient (API) throughout the product. 2) Scope This…
SOP for Particle Size Analysis Standard Operating Procedure for Particle Size Analysis 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for performing particle size analysis of pharmaceutical formulations, including Intramuscular (IM) and Subcutaneous (SC) injections, to ensure uniformity and consistency of the product. 2) Scope This SOP applies…
SOP for Filling Volume Accuracy Standard Operating Procedure for Filling Volume Accuracy 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish a procedure for ensuring the accuracy of filling volumes in the manufacturing of injectable products, including Intramuscular (IM) and Subcutaneous (SC) injections, to maintain product consistency and compliance with regulatory…
SOP for Formulation Development of IM and SC Injections Standard Operating Procedure for Formulation Development of Intramuscular (IM) and Subcutaneous (SC) Injections 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for the formulation development of Intramuscular (IM) and Subcutaneous (SC) injections to ensure that the final product is…
Read More “SOP for Formulation Development of IM and SC Injections” »